Learning about side effects of cancer drugs is an evolving science, which includes weighing drugs’ risks and benefits, and monitoring for adverse reactions.
How does the FDA monitor drugs after the approval process?
Can angiogenesis inhibitors also increase cancer patients’ risk of developing blood clots in the veins?
You can report adverse drug reactions directly to the FDA’s MedWatch program at www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm.
Or, ask your physician to contact the FDA or the manufacturer of the medicine.
For drug safety information, including medication guides and warning letters, visit www.fda.gov/Drugs.